FierceHealthcareFierceHealthITFierceHealthFinanceHospital Impact   FiercePharmaFierceBiotechFierceSarbox
Syndicate content

heart disease news from FierceHealthcare

News

New study questions benefits of $10 billion angioplasty industry

Over recent months we've seen several studies that questioned the benefit of angioplasty in many of the cases in which it is used; with the number of angioplasties performed per year having increased... Read more...

Few drugs being developed for pregnant women

While the subject isn't discussed much, it's an open secret that there are few drugs that serve the health needs of the 4 million American women who give birth each year. In fact, in many cases... Read more...

Congress passes bill banning genetic discrimination

In a landmark action, Congress has approved a bill banning genetic discrimination. The bill, the Genetic Information Nondiscrimination Act, forbids employers and insurance companies from using... Read more...

Tobacco giants funding MA universities' research

It's discomforting--the more you look, the more you find tobacco companies funding medical research. Last week, we learn that a 2006 study concluding that 80 percent of lung cancer deaths could be... Read more...

MD-patient communication cuts heart disease risk

A new study suggests that good doctor-patient communication can cut the risk of heart disease, whether that communication is done in person or via the Internet. The study, conducted by Temple... Read more...

MN officials focus on chronic disease care

Increasingly, states are beginning to focus on management of chronic diseases as a means for getting massive healthcare costs under control. This week, Minnesota is joining the pack. Legislators... Read more...

Seattle-area healthcare "checkup" finds deficiencies

A Seattle-area health alliance has conducted what it calls a "community checkup," examining care for more than 1.6 million patients--and concluded that performance was below current standards on many... Read more...

ALSO NOTED: Stryker recalls hip surgery products; Heart disease deaths fall below 2010 goal; and much more...

> Medical technology firm Stryker Corp. is recalling some of its hip surgery products after getting a warning from regulators. Read more...

Study: Blacks avoid clinical trials

It seems that many black U.S. residents are less likely to participate in clinical studies, possibly due to distrust of physicians and fears that they might be harmed by participation, according to a... Read more...

Defibrillator use delays common, harmful

Too often, hospital patients with ventricular arrhythmias aren't treated with defibrillators soon enough, a problem that may have an impact on their survival, according to a new study published in... Read more...

Get more heart disease coverage at: